Brokerages Set Oscar Health, Inc. (NYSE:OSCR) Price Target at $16.88

by · The Cerbat Gem

Shares of Oscar Health, Inc. (NYSE:OSCR – Get Free Report) have received a consensus recommendation of “Hold” from the ten ratings firms that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $16.8750.

Several equities research analysts have issued reports on OSCR shares. UBS Group restated a “neutral” rating and set a $15.00 price objective on shares of Oscar Health in a research report on Wednesday, February 11th. Barclays set a $18.00 target price on Oscar Health and gave the company an “equal weight” rating in a research report on Monday, January 5th. Stephens started coverage on Oscar Health in a research note on Thursday, December 11th. They set an “equal weight” rating and a $17.00 target price on the stock. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target for the company in a research note on Thursday, February 12th. Finally, Piper Sandler raised Oscar Health from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $13.00 to $25.00 in a report on Tuesday, November 25th.

Get Our Latest Analysis on Oscar Health

Oscar Health Price Performance

NYSE:OSCR opened at $13.22 on Friday. The company has a market cap of $3.93 billion, a P/E ratio of -7.59 and a beta of 1.90. The firm’s fifty day moving average price is $14.53 and its two-hundred day moving average price is $16.47. Oscar Health has a one year low of $11.20 and a one year high of $23.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.96 and a quick ratio of 0.96.

Oscar Health (NYSE:OSCR – Get Free Report) last posted its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The company had revenue of $2.81 billion for the quarter, compared to analyst estimates of $3.12 billion. During the same quarter in the prior year, the business posted ($0.62) EPS. The business’s quarterly revenue was up 17.3% compared to the same quarter last year. Equities analysts expect that Oscar Health will post 0.69 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 23,038 shares of the business’s stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $17.65, for a total value of $406,620.70. Following the completion of the sale, the insider owned 350,180 shares of the company’s stock, valued at approximately $6,180,677. The trade was a 6.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders sold a total of 138,835 shares of company stock worth $2,298,269 over the last three months. 25.11% of the stock is currently owned by company insiders.

Institutional Trading of Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Envestnet Asset Management Inc. raised its position in shares of Oscar Health by 200.9% in the second quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock valued at $648,000 after buying an additional 20,171 shares in the last quarter. Udine Wealth Management Inc. grew its position in Oscar Health by 138.4% during the third quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company’s stock worth $2,774,000 after buying an additional 85,083 shares in the last quarter. Q Fund Management Hong Kong Ltd bought a new position in Oscar Health during the 3rd quarter worth $5,940,000. Jump Financial LLC increased its stake in Oscar Health by 798.3% during the 2nd quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock worth $30,906,000 after acquiring an additional 1,281,032 shares during the period. Finally, State of Michigan Retirement System bought a new stake in shares of Oscar Health during the 3rd quarter valued at $27,448,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

(Get Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

Read More